Freya Pharma Solutions, a company focusing on therapies for women diagnosed with Female Sexual Disorders (FSD), announced the appointment of Christa van Kan, MSc as Director Clinical Operations. She brings more than 25 years of clinical operations and trial management experience to the company.
She was most recently Interim Director Clinical Operations at Healx, a Cambridge (UK) AI drug discovery company, overseeing all clinical projects performed by the company and training and coaching the clinical team members. Prior to Healx, van Kan was co-founder in 1998 and Director Clinical Operations of PSR Group, a Dutch CRO.